Association between pupillary light reflex and sensory behaviors in children with autism spectrum disorders.
C Daluwatte, J H Miles, J Sun...
https://pubmed.ncbi.nlm.nih.gov/25528080/Actively Recruiting
Led by Schweitzer Engineering Laboratories · Updated on 2026-10-29
330
Participants Needed
4
Research Sites
2 weeks
Total Duration
Autism spectrum disorder ASD affects communication, social interaction, and behavior in children. Early identification of ASD helps families access support sooner. This study evaluates the APS Detect12 handheld pupillometer, a device that measures pupil responses to light, to help screen for ASD in children aged 2 to 4 during routine pediatric healthcare visits. Researchers aim to compare the devices screening results with standard clinical ASD assessments to determine its accuracy. The study involves using the APS Detect device to measure pupillary light reflex in children, generating an Autism Pupil Screening APS score to estimate ASD risk. Participants undergo standard clinical evaluations for ASD diagnosis alongside the pupillometer assessments. A precision sub-study will assess the consistency of APS scores when measured by different healthcare professionals using multiple assessments. Participants will attend routine pediatric visits where the device and standard screening tools are used. Researchers will collect data including APS scores and diagnostic outcomes to evaluate device performance, safety, and suitability for clinical use. The primary outcome measures sensitivity and specificity of the APS score in classifying ASD, with additional measures including predictive values. The study period from enrollment to final testing visits lasts 14 to 30 days.
CONDITIONS
Effectiveness of the Autism Pupil Screen (APS) Detect Pupillometer for Identifying Autism Spectrum Disorder (ASD) in Routine Healthcare
G
Georgina Lynch, PhD
A
Alyssa Knight
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Schweitzer Engineering Laboratories
Lead Sponsor
Palouse Pediatrics
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 14 to 30 days
Participants undergo pupillometry testing using the APS Detect device alongside standard clinical evaluations to assess for autism spectrum disorder.
1 to multiple visits depending on sub-study participation
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
C Daluwatte, J H Miles, J Sun...
https://pubmed.ncbi.nlm.nih.gov/25528080/Dinalankara M R Dinalankara, Judith H Miles, T Nicole Takahashi...
https://pubmed.ncbi.nlm.nih.gov/28188684/Whitney Guthrie, Kate Wallis, Amanda Bennett...
https://pubmed.ncbi.nlm.nih.gov/31562252/Pär Nyström, Teodora Gliga, Elisabeth Nilsson Jobs...
https://pubmed.ncbi.nlm.nih.gov/29735992/Georgina T F Lynch, Stephen M James, Mark VanDam
https://pubmed.ncbi.nlm.nih.gov/29087041/Pär Nyström, Gustaf Gredebäck, Sven Bölte...
https://pubmed.ncbi.nlm.nih.gov/25750705/Georgina Lynch
https://pubmed.ncbi.nlm.nih.gov/30469373/Schweitzer Engineering Laboratories
Lead Sponsor
Palouse Pediatrics
Collaborating Sponsor